DCP Loses Cannabis Regulator Role Amid Retaliation Scandal as New Oversight Office Emerges
April 9, 2025 | Hartford, CT — In a dramatic shakeup for Connecticut’s cannabis regulation, the state has removed marijuana oversight from the Department of Consumer Protection’s (DCP) Drug Control Division — less than a month after the agency was accused of conducting a retaliatory inspection against a vocal industry critic.
A brand-new division has been created within DCP to handle licensing, inspections, and enforcement for both medical and recreational cannabis — effectively stripping power from the same leadership responsible for the controversial incident.
Full article: ctmirror.org/2025/04/09/ct-cannabis-inspection-consumesYaR0Y2sd-rrBAY9AJ7SyyXg
Retaliation Sparks Overhaul
The shift came after a March inspection at Affinity Grow, a cannabis cultivation facility, was conducted just one day after its CEO, Rino Ferrarese, criticized the state’s testing protocols during a public legislative hearing.
DCP Commissioner Bryan Cafferelli apologized for the inspection, calling it an “unannounced compliance check” — but failed to provide any legitimate justification for the timing or necessity of the visit.
DCP has refused to disclose who authorized the inspection. The visit was widely interpreted as retaliation, accelerating what had been a long-planned agency reorganization.
A New Office, Led by a Familiar Face
The new cannabis regulatory office will be led by Lila McKinley, a DCP attorney who helped draft Connecticut’s adult-use regulations. McKinley has longstanding ties to the cannabis industry and previously served as the legal director of the Drug Control Division.
The move aims to create clearer boundaries between cannabis and pharmaceutical enforcement — a change many in the industry believe is long overdue.
Praise from Industry Insiders — With a Caveat
Not surprisingly, corporate-aligned voices like Ben Zachs of Fine Fettle and Adam Wood of the Connecticut Cannabis Chamber of Commerce celebrated the news.
Zachs called the change a sign the industry is “maturing,” while Wood said it was “well-timed” given the expansion of dispensaries and manufacturing sites statewide.
But both figures represent highly pro-industry interests — with a history of pushing policies that benefit large operators and sideline small businesses, patients, and social equity applicants. Their praise should be understood in that context.
What This Means for Connecticut’s Cannabis Future
- Retaliation Was a Tipping Point: A seemingly punitive inspection helped force overdue structural changes.
- Cannabis Gets Its Own Regulator: Oversight will no longer be handled by the same officials regulating opioids and pharmacies.
- Trust Remains in Question: Reform advocates are cautiously optimistic but warn that corporate influence still dominates the conversation.
As this new office takes shape, the real test will be whether it serves all stakeholders — or continues to favor large players behind closed doors.
Original reporting via CT Mirror: ctmirror.org/2025/04/09/ct-cannabis-inspection-consumesYaR0Y2sd-rrBAY9AJ7SyyXg
This story was originally published by Connecticut CannaTimes on Facebook on April 9, 2025 and was migrated to this website on October 16, 2026. The publication date above is the original date.


